期刊文献+

胡小芳教授治疗抗磷脂综合征致复发性流产经验 被引量:1

Experience of Hu Xiaofang in Treating Recurrent Abortion Caused by Antiphospholipid Syndrome
在线阅读 下载PDF
导出
摘要 本文总结了胡小芳教授运用寿胎丸合四君子汤加减治疗脾肾两虚血瘀型抗磷脂综合征致复发性流产的临床经验。胡小芳认为抗磷脂综合征致复发性流产的主要病机为脾肾两虚、瘀阻胞宫。治疗除孕前的中医药调理,更强调试孕当月在B超下监测排卵,卵泡排出后立即开始保胎治疗,意在提前安胎,予培其损,采用补肾健脾活血法,改善机体凝血功能及免疫功能,增加子宫动脉血流量,提高活产率。 This article summarizes Professor Hu Xiaofang’s clinical experience in treating recurrent miscarriage caused by antiphospholipid syndrome of deficiency of both spleen and kidney and blood stasis by using Shoutaiwan and Sijunzi Decoction.Hu Xiaofang believes that the main etiology and pathogenesis of recurrent miscarriage caused by antiphospholipid syndrome are deficiency of both spleen and kidney and stasis blocking the uterus.Treatment of traditional Chinese medicine before pregnancy,stronger adjustment of ovulation in the month of pregnancy,monitoring of ovulation under B-ultrasound,fetal preservation treatment will be started immediately after the follicle is discharged,intended to prevent the fetus in advance,and prevent its damage,and adopt the method of invigorating the kidney,strengthening the spleen and promoting blood circulation to improve blood clotting Function and immune function,increase uterine artery blood flow,improve the rate of live birth.
作者 李佩瑶 刘星妤 胡小芳 LI Peiyao;LIU Xingyu;HU Xiaofang(The First Clinical Medical College,Henan University of Traditional Chinese Medicine,Henan Province,Zhengzhou 450000,China;Department of Reproductive Medicine,Henan University of Traditional Chinese Medicine,Henan Province,Zhengzhou 450000,China)
出处 《中国中医药现代远程教育》 2021年第2期87-89,共3页 Chinese Medicine Modern Distance Education of China
关键词 滑胎 复发性流产 抗磷脂综合征 胡小芳 脾肾两虚 血瘀 recurrent spontaneous abortion antiphospholipid syndrome Hu Xiaofang spleen and kidney deficiency and blood stasis
  • 相关文献

参考文献5

二级参考文献80

  • 1陈惠萍,胡峰.抗磷脂综合征肾损害[J].肾脏病与透析肾移植杂志,2004,13(5):490-492. 被引量:3
  • 2张建平,林其德,李大金,罗颂平,张清学,冯淑英,刘玉昆.复发性流产的诊断与治疗[J].现代妇产科进展,2006,15(7):481-492. 被引量:213
  • 3孙立新,谈勇.封闭抗体不足性复发性自然流产的临证心得[J].南京中医药大学学报,2007,23(3):194-195. 被引量:12
  • 4Levine JS, Branch DW, Rauch J. The antiphospholipid antibody syndrome[J]. New England Medicine, 2002, 346:752-763.
  • 5Lim W, Crowther MA, Eikelboom JW, et al. Management of antiphospholipid antibody syndrome :a systemic review[J]. JAMA, 2006, 295 : 1050-1057.
  • 6Groot P, Lutters B, Derksen R, et al.Lupus anticoagulants and the risk of a first episode of deep vein thrombosis[J]. Thromb Haemost, 2005, 3:1993-1997.
  • 7Cervera R, Khamashta M, Shoenfeld Y, et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period : a multicenter prospective study of 1000 patients[J]. Ann Rheum Dis, 2009,68 : 1428-1432.
  • 8Buceiarelli S, Espinosa G, Cervera R, et al. Mortality in the catastrophic antiphospholipid syndrome :causes of death and prognostic factors in a series of 250 patients[J]. Arthritis Rheum, 2006, 54 (8) :2568-2576.
  • 9Guillermo R, Mark C, Ware B, et al. Antiphospholipid syndrome[J]. Lancet, 2010, 376 : 1498-1508.
  • 10Richard C, Gerard E. Antiphospholipid syndrome :long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies[J]. Expert Opinion Ther Targets, 2010, 14 (12) : 1279-1280.

共引文献61

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部